Muscular Dystrophy Trial, Recruiting (NCT06093100)

Muscular Dystrophy Trial, Recruiting NCT06093100 Sponsor: Vanderbilt University Medical Center Condition: Muscular Dystrophy

Printed from Voxsanity (voxsanity.com.au) — NCT06093100 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Muscular Dystrophy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are male and aged 10 years or older
You have been diagnosed with Duchenne Muscular Dystrophy (DMD), confirmed either through a muscle biopsy or a genetic test
If you are 18 or older, you are able to give your own consent to take part
If you are under 18, a parent or guardian can give consent on your behalf, and you are also asked to agree to take part
You are able to have a cardiac MRI scan (a detailed heart scan) without needing sedation

Who may not be able to join:

You do not wish to take part in the trial
You have been diagnosed with diabetes before the study starts, or you have taken insulin or other diabetes medications within the 4 weeks before the study
You are unable to go without food or drink for 10 hours (fasting)
You have a pacemaker, an implantable heart device (such as a defibrillator), or any other implanted medical device
In the opinion of the medical team running the trial, you are unable to follow the study procedures for any reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jaclyn Tamaroff, MD, Vanderbilt University Medical Center

Phone: 615-875-7853

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06093100

Sponsor: Vanderbilt University Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Muscular Dystrophy

Trial contact: 615-875-7853

More information: https://clinicaltrials.gov/study/NCT06093100

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are male and aged 10 years or older
You have been diagnosed with Duchenne Muscular Dystrophy (DMD), confirmed either through a muscle biopsy or a genetic test
If you are 18 or older, you are able to give your own consent to take part
If you are under 18, a parent or guardian can give consent on your behalf, and you are also asked to agree to take part
You are able to have a cardiac MRI scan (a detailed heart scan) without needing sedation

Who may not be able to join:

You do not wish to take part in the trial
You have been diagnosed with diabetes before the study starts, or you have taken insulin or other diabetes medications within the 4 weeks before the study
You are unable to go without food or drink for 10 hours (fasting)
You have a pacemaker, an implantable heart device (such as a defibrillator), or any other implanted medical device
In the opinion of the medical team running the trial, you are unable to follow the study procedures for any reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Vanderbilt University Medical Center

Registry

ClinicalTrials.gov

Start date

10 July 2024

Est. completion

1 December 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of hyperglycemia; Standard deviation of the mean R-to-R segment (SDANN)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov